Upcycling plastic waste into high-capacity sodium-battery anodes

Plastic waste upcycling into high-performance battery anodes for the next-generation of fast-charging and low-cost sodium-ion batteries (NIBs).

A novel dry electrode manufacturing technology

A binder-less, fully dry, room temperature electrode manufacturing technology - a sustainable, cost-effective, and efficient alternative.

A noise-reduction protocol for EPR/NMR and quantum sensing

Quantum-compatible cooling technique for faster, more sensitive RF, EPR, and NMR measurements at room-temperature.

PET plastic upcycling into clean H2 and valuable chemicals

A technology that transforms plastic waste into green H2 and high value, sustainable chemicals at low cost.

IonMembrane Technologies: Next-generation ion exchange membranes for energy applications

A new generation of ion exchange membranes for electrochemical energy conversion and storage applications.

A novel targeted drug delivery system

RBCV-based system enables targeted, stable thrombolytic drug delivery to clots, reducing bleeding risks in thrombosis treatment.

Human monoclonal antibodies to COVID-19

Broad neutralising monoclonal antibodies identified for SARS-CoV-2, enabling therapeutic strategies against coronaviruses.

First-in-class drug candidate for treatment of multiple myeloma and Diffuse Large B Cell Lymphoma

DTP3 is a first-in-class GADD45β/MKK7 inhibitor targeting the NF-κB pathway.

EffiTrap: comprehensive and real-time defect analysis for semiconductors

Technology for advanced defect analysis in semiconductors, sensors, photonics, laser materials, and photovoltaics.

Long-lasting nanoparticles for controlled release drug delivery

A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.

Two-gene signature diagnostic test for differentiating between viral and bacterial infections in children

A simple, whole blood 2-gene expression signature that distinguishes bacterial infection from both viral infection and childhood inflammatory diseases.

MicroRNA plasma markers for small-for-gestational-age (SGA) births

Non-invasive blood test detects placental miRNAs at 13 weeks to predict small-for-gestational-age births, improving prenatal outcomes.